Annual Drug Patent Expirations for RYZUMVI Ryzumvi is a drug marketed by Ocuphire and is included in one NDA. The generic ingredient in RYZUMVI is phentolamine mesylate. Additional details are…
The post New patent for Ocuphire drug RYZUMVI appeared fir…
Annual Drug Patent Expirations for SUNOSI Sunosi is a drug marketed by Axsome Malta and is included in one NDA. It is available from two suppliers. There are twenty-three patents…
The post New patent for Axsome Malta drug SUNOSI appeared first on DrugP…
Annual Drug Patent Expirations for AUVELITY Auvelity is a drug marketed by Axsome and is included in one NDA. It is available from one supplier. There are one hundred and…
The post New patent for Axsome drug AUVELITY appeared first on DrugPatentWatch -…
Annual Drug Patent Expirations for MOUNJARO Mounjaro is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…
The post New patent for Eli Lilly drug MOUNJARO appeared first on DrugPatentWatch – Ma…
Annual Drug Patent Expirations for FLONASE+SENSIMIST+ALLERGY+RELIEF Flonase Sensimist Allergy Relief is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from two suppliers. There…
The post New patent for Glaxosmithkli…
New patent for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF Read Post »
This chart shows the drugs with the most patents in Eurasian Patent Organization. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
The post Which pharmaceutical drugs have the most drug patents i…
Which pharmaceutical drugs have the most drug patents in Eurasian Patent Organization? Read Post »
This chart shows the drugs with the most patents in Peru. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Peru? appe…
Which pharmaceutical drugs have the most drug patents in Peru? Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Germany. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Germany? Read Post »
Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. It is available from two suppliers. There are eighteen patents protecting…
The post New patent for Intra-cellular drug CAPLYTA appeared …
This chart shows the patent expirations for capsule dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
The post Capsule dosed drug patent expirations by year appeared first on DrugPatentWatc…
Get new actionable insights and updates from BiotechBlog
